Results

Total Results: 744 records

Showing results for "calculate".

221. Quantitative Synthesis: Chapter 1. Decision To Combine Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-1.pdf
     July 01, 2019 - Quantitative Synthesis: Chapter 1. Decision To Combine Trials Quantitative Synthesis Chapter 1. Decision to combine trials Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guide www.ahrq.gov Presenter Presentation Notes Prioritization and Selecti…

222. Disposition of Comments Report for The Patient-Centered Medical Home (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_disposition-comments.pdf
     July 03, 2012 - Disposition of Comments Report for The Patient-Centered Medical Home Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1178 Published Online: July 3, 2012 Comparative Effectiveness Research Review Disposition of Comments Report Researc…

223. BLUEPRINT FOR A FUTURE DISTRIBUTED RESEARCH NETWORK (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
     June 01, 2010 - • Case-mix adjusted comparisons: calculate incidence rates of myocardial infarction and stroke among

224. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
     September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…

225. Covariate Selection for Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
     January 01, 2013 - Covariate Selection for Observational Comparative Effectiveness Research Considerations for Statistical Analysis in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Considerations for Statistical Analysis in Observational Comparative Effe…

226. FRN 39 - Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
     February 01, 2013 - FRN 39 - Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs Future Research Needs Paper Number 39 Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs Future Research Needs Paper Number 39 Nonoperative and Operative Treatments for Rotator Cuf…

227. Disposition of Comments Report for Pressure Ulcer Risk Assessment and Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
     May 08, 2013 - For eg., Is it what the study authors reported or did the review authors calculate relative risk for

228. Mixed MethodsReview -Integrating Palliative Care with Chronic Disease Management in Ambulatory Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
     November 21, 2019 - For continuous outcomes, we will calculate a standardized mean difference using a random-effects model … In a situation where dichotomous outcomes are presented, we will calculate a pooled effect estimate

229. Research Protocol: Care Interventions for PeopleWith Dementia (PWD) and Their Caregivers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
     February 22, 2019 - outcomes measured with instruments that lack established thresholds to measure improvement, we will calculate … We will calculate risk ratios and absolute risk differences with the corresponding 95 percent confidence

230. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
     October 01, 2010 - comparisons were statistically significant and did not provide patient numbers, precluding our ability to calculate

231. Alcohol-Misuse Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
     April 28, 2010 - cThese data are 6-month outcomes; for consumption for young adults, we were unable to calculate pooled … Effect Size (95% CI) Strength of Evidence Increased smoking No difference between groups (unable to calculate … Moderate Anxiety No difference between groups (unable to calculate effect size).

232. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management_research-protocol.pdf
     June 06, 2011 - We will initially review 100 citations in triplicate and calculate kappa values to estimate inter-reviewer

233. Arthritis-Knee-Physical-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
     November 01, 2012 - Furthermore, variability in the definitions of outcomes required us to calculate standardized mean differences

234. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_executive.pdf
     November 01, 2009 - Layout 1 Background Radiotherapy with charged particles can potentially deliver maximal doses while minimizing irradiation of surrounding tissues. It may be more effective or less harmful than other forms of radiotherapy for some cancers. Currently, seven centers in the United States have facilities for particle (pr…

235. Cer-238-Cervical-Ripening-Appendix-E-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
     January 01, 2017 - - Multiparous PGE2 gel vs. placebo Length of labor in L&D: 11.2 (1.3) vs. 7.1 (4.4), p= NS (cannot calculate … PGE2 gel vs. placebo Length of labor in L&D, mean h (SD): 10.7 (5.1) vs. 15.3 (7.6), p= 0.035 (cannot calculate

236. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults Purpose of Review To assess adverse events of antidepressants in the treatment of major depressive disorder in adults 65 years of age or older. Key Messages In people 65 years of age or older: • Serotoni…

237. Progestogens-Preterm-Birth Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
     September 01, 2012 - 1 Comparative Effectiveness Review Number 74 Progestogens for Prevention of Preterm Birth Executive Summary Introduction Burden of Preterm Birth Birth before completion of 37 weeks of pregnancy is considered preterm. These early births are associated with more than 85 percent of all perinatal morbidity an…

238. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-treatment_research-protocol.pdf
     November 08, 2011 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: November 8, 2011 Evidence-based Practice Center Systematic Review Protocol Pressure Ulcer Treatment Strategies: A Comparative Effectiveness Review I. Background and Objectives for t…

239. Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
     August 01, 2024 - Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review Comparative Effectiveness Review Number 273 Treatment of Stages I–III Squamous Cell Anal Cancer: A Systematic Review Executive Summary Main Points • For the ini…

240. Allergy-Seasonal Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
     July 01, 2013 - 1 Comparative Effectiveness Review Number 120 Treatments for Seasonal Allergic Rhinitis Executive Summary Background Seasonal allergic rhinitis (SAR), also known as hay fever, is an allergic reaction in the upper airways that occurs when sensitized individuals encounter airborne allergens (typically tree, gras…